Lai San Tham

5PUBLICATIONS
17CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2026
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept.

Shobha Bhattachar, Lai San Tham, Beth Tidemann-Miller

|Aug 22, 2025
A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules.

Maria M Posada, Karen B Schneck, Bridget L Morse

|Aug 20, 2025
Mazdutide reduces body weight in adults with overweight or obesity: A high-dose Phase 1 trial.

Shobha N Bhattachar, Lai San Tham, Yan Li

|Jun 17, 2025
Evaluation of Four Semi-Mechanistic Models for Predicting Glycemic Control With a Glucagon Receptor Antagonist in People With Type 2 Diabetes.

Austin Yue Feng Tan, Karen Schneck, Parag Garhyan

Pageof 1